Developer docs
API playgroundTry for free, no card

Search company profiles

Juno Bio

Full company profile

uuid0007qto

Namestring
Juno Bio
Legal namestring
Juno Bio Limited
Websiteurl
juno.bio
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Juno Bio is a women's health biotechnology company that operates an at-home vaginal microbiome testing service targeting women and people with vaginas, particularly those experiencing recurrent infections, fertility concerns, or general wellness curiosity. The company's flagship product is the Juno Bio Vaginal Microbiome Test, an at-home kit that uses next-generation sequencing (NGS) to identify over 45,000 bacteria and yeast species from a single vaginal swab. Results include Community State Type (CST I–V) classification, microbial load analysis, identification of beneficial versus disruptive organisms, and a personalized action plan, delivered within 5–10 days via a private dashboard with 1:1 consultation from a vaginal coach. Samples are processed in a CLIA-certified high-complexity clinical laboratory (CLIA ID 05D2314895) located in Oakland, California, with results reported as clinical-grade in most US states and as wellness-only in New York, Maryland, Pennsylvania, Rhode Island, and internationally.

The company operates a direct-to-consumer e-commerce model with two principal revenue streams: a one-time test purchase at $149.00 and a subscription offering that delivers a test every three months at $99.00 (approximately 34% lower per test). A complementary channel allows registered healthcare practitioners — including naturopaths, osteopaths, nurses, pharmacists, and medical doctors — to offer Juno Bio tests directly to their clients with expert scientific interpretation support. Juno Bio also partners with Flex to enable HSA/FSA payments at checkout, providing 30–40% net savings for eligible US customers. Marketing is driven by content (an extensive educational blog), organic social (Instagram, TikTok, Facebook, X), earned media placements (Vogue, Marie Claire, TechCrunch), and the Flex partnership. The company ships to 50+ countries and has helped more than 10,000 people on their vaginal health journeys, with a 4.8/5 customer satisfaction rating across 111 verified reviews.

Juno Bio maintains a dual legal structure: Juno Bio Limited, registered in London, United Kingdom (headquarters), and Juno Bio, Inc., incorporated in Delaware, USA. The company was co-founded by Hana Janebdar (CEO, MSc) and Dr. Leighton Turner (CTO, PhD in Molecular Genetics), who lead a small team (1–10 employees) described as world-class microbiome scientists. Early-stage funding was raised in 2020 from AI Seed, Pink Salt Ventures, and Acequia Capital (AceCap); no subsequent funding rounds are disclosed in the available data. The company's stated mission is to close the gender health gap by advancing scientific understanding of the vaginal microbiome through its testing platform and aggregated anonymized research data.

Short descriptiontext

Juno Bio is a London-based women's health biotechnology company that sells an at-home vaginal microbiome test using next-generation sequencing to profile 45,000+ bacteria and yeast from a single swab, serving women with recurrent infections, fertility concerns, and wellness interest via direct e-commerce, subscription, and a healthcare provider channel.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
vaginal microbiome testing, at-home diagnostic testing, microbiome sequencing services, women's health diagnostics, microbiome bioinformatics
Industry2 codes
1Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal)
CodeHLAAAFAHPrimaryYes
2Microbiome Analytics, Sequencing & Bioinformatics Platforms
CodeHLAAAFAIPrimaryNo
NAICS code2 codes
  • Medical Laboratories621511
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Consumer Women's Health Diagnostics
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Single Test Purchase
TypeOne Time License
Description

One-time purchase of vaginal microbiome test kit at $149.00. Includes complete bacterial and yeast microbiome profile, free US shipping, HSA/FSA eligibility, and 1:1 consultation with vaginal coach.

juno.bio
2Subscription Testing
TypeSubscription Recurring
Description

Recurring subscription model delivering one test every 3 months at $99.00 (save $50 vs single purchase). Designed for ongoing monitoring of vaginal microbiome over time. Cancel anytime after minimum of two payments.

juno.bio
3Gift Cards
TypeOne Time License
Description

Juno Bio Gift Card ($149.00) and Vaginal Microbiome Test Gift Card ($174.00) available for purchase as gifts.

juno.bio
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain
Pricing details2 tiers
1Single Test - One-time vaginal microbiome test
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Single test purchase at $149.00. Includes comprehensive microbiome profile, personalized report, and 1:1 consultation with vaginal coach. Free US shipping, HSA/FSA eligible.

juno.bio
2Subscription - Recurring 3-month testing
ModelSubscriptionBilling cadenceAnnual
Notes

$99.00 per test delivered every 3 months. Save $50 compared to single purchase. Includes all test features. Cancel anytime after minimum 2 payments.

juno.bio
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Juno Bio sells an at-home vaginal microbiome test kit that customers order online, self-collect via vaginal swab, and mail to a CLIA-certified lab for next-generation sequencing analysis. The company delivers a comprehensive bacterial and yeast microbiome profile (45,000+ microbes), Community State Type classification, microbial load analysis, and personalized recommendations through a private online dashboard, including a 1:1 consultation with a vaginal coach, with options for one-time purchase or a recurring 3-month subscription.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 10,000+ customers helped on their vaginal health journeys
+2 more records
Product overview1 text field

Juno Bio offers a single primary product—the Juno Bio Vaginal Microbiome Test—alongside gift card variants. The core test is an at-home vaginal microbiome screening service using next-generation sequencing technology to provide comprehensive bacterial and yeast profiling. Results are delivered via a private dashboard with 1:1 consultation with a vaginal coach included. The company also offers gift cards for the test and a separate general gift card product.

Product and service3 records
1Juno Bio Vaginal Microbiome Test
CategoryAt-home diagnostic test
Description

An at-home vaginal microbiome test that uses next-generation sequencing to identify over 45,000 bacteria and yeast species from a single self-collected swab. Results are delivered within 5–10 days and include Community State Type classification, a full microbiome profile, and personalized wellness recommendations along with a 1:1 consultation with a vaginal coach; designed for adult women and people with vaginas seeking personal vaginal-health insights.

2Juno Bio Gift Card
CategoryGift card
Description

A digital gift card (priced at $149.00) that grants the recipient access to Juno Bio's comprehensive at-home vaginal microbiome testing kit and detailed analysis report, delivered via email with an optional personalized message.

3Juno Bio Vaginal Microbiome Test Gift Card
CategoryGift card
Description

A dedicated gift card (priced at $174.00) specifically for the Juno Bio Vaginal Microbiome Test, granting recipients personalized vaginal health insights and a comprehensive microbial composition analysis.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeGTM or Marketing Partner
Description

Juno Bio has partnered with Flex to enable customers to use their Health Savings Account (HSA) or Flexible Spending Account (FSA) to purchase vaginal microbiome tests. Flex provides an asynchronous telehealth visit as part of checkout, generating a Letter of Medical Necessity within 24 hours of purchase, enabling HSA/FSA payment and resulting in 30-40% net savings for customers.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Atlas Biomed provides D2C gut microbiome and DNA testing using NGS with personalized recommendations. Broader indication set but similar NGS-D2C model.

TypeDirect peer
Description

Evvy offers an at-home vaginal microbiome test using NGS with similar screening coverage and D2C positioning. Closest direct competitor to Juno Bio.

TypeDirect peer
Description

Tiny Health provides NGS-based microbiome testing for women and infants with a D2C subscription model. Targets overlapping use cases including fertility and baby microbiome.

TypeDirect peer
Description

Viome sells D2C gut and oral microbiome tests using NGS + AI with subscription recommendations. Different indications but comparable technology and GTM motion.

5Daye
TypeEmerging player
Description

UK-based vaginal health brand selling tampons, cramp care, and at-home screening. Same consumer segment with adjacent rather than overlapping microbiome testing focus.

TypeDirect peer
Description

Biohm provides gut and vaginal microbiome testing for consumers and providers with personalized probiotic recommendations. Direct overlap in vaginal microbiome and provider channel.

TypeDirect peer
Description

Thryve offers microbiome testing and personalized probiotics for consumers and brands. Direct overlap in microbiome sequencing services and recommendations.

TypeBroad incumbent
Description

Seed Health develops microbiome-based probiotics with consumer products and clinical research. Adjacent rather than direct — overlapping microbiome IP rather than head-to-head testing.

TypeBroad incumbent
Description

Thorne is a large practitioner-grade supplements and at-home testing brand offering microbiome and women's health products as part of a broader portfolio rather than a vaginal specialist.

10Jona
TypeEmerging player
Description

Jona offers D2C gut microbiome sequencing with AI-driven personalized insights. Same NGS+AI+D2C axis but broader indication than Juno Bio's current niche.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Juno Bio

Consumer Women's Health Diagnosticsjuno.bio

Juno Bio is a London-based women's health biotechnology company that sells an at-home vaginal microbiome test using next-generation sequencing to profile 45,000+ bacteria and yeast from a single swab, serving women with recurrent infections, fertility concerns, and wellness interest via direct e-commerce, subscription, and a healthcare provider channel.

What Juno Bio does

Juno Bio is a women's health biotechnology company that operates an at-home vaginal microbiome testing service targeting women and people with vaginas, particularly those experiencing recurrent infections, fertility concerns, or general wellness curiosity. The company's flagship product is the Juno Bio Vaginal Microbiome Test, an at-home kit that uses next-generation sequencing (NGS) to identify over 45,000 bacteria and yeast species from a single vaginal swab. Results include Community State Type (CST I–V) classification, microbial load analysis, identification of beneficial versus disruptive organisms, and a personalized action plan, delivered within 5–10 days via a private dashboard with 1:1 consultation from a vaginal coach. Samples are processed in a CLIA-certified high-complexity clinical laboratory (CLIA ID 05D2314895) located in Oakland, California, with results reported as clinical-grade in most US states and as wellness-only in New York, Maryland, Pennsylvania, Rhode Island, and internationally.

The company operates a direct-to-consumer e-commerce model with two principal revenue streams: a one-time test purchase at $149.00 and a subscription offering that delivers a test every three months at $99.00 (approximately 34% lower per test). A complementary channel allows registered healthcare practitioners — including naturopaths, osteopaths, nurses, pharmacists, and medical doctors — to offer Juno Bio tests directly to their clients with expert scientific interpretation support. Juno Bio also partners with Flex to enable HSA/FSA payments at checkout, providing 30–40% net savings for eligible US customers. Marketing is driven by content (an extensive educational blog), organic social (Instagram, TikTok, Facebook, X), earned media placements (Vogue, Marie Claire, TechCrunch), and the Flex partnership. The company ships to 50+ countries and has helped more than 10,000 people on their vaginal health journeys, with a 4.8/5 customer satisfaction rating across 111 verified reviews.

Juno Bio maintains a dual legal structure: Juno Bio Limited, registered in London, United Kingdom (headquarters), and Juno Bio, Inc., incorporated in Delaware, USA. The company was co-founded by Hana Janebdar (CEO, MSc) and Dr. Leighton Turner (CTO, PhD in Molecular Genetics), who lead a small team (1–10 employees) described as world-class microbiome scientists. Early-stage funding was raised in 2020 from AI Seed, Pink Salt Ventures, and Acequia Capital (AceCap); no subsequent funding rounds are disclosed in the available data. The company's stated mission is to close the gender health gap by advancing scientific understanding of the vaginal microbiome through its testing platform and aggregated anonymized research data.

Juno Bio firmographics

Firmographics
Name
Juno Bio
Legal name
Juno Bio Limited
Website
https://juno.bio
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
Juno Bio is a London-based women's health biotechnology company that sells an at-home vaginal microbiome test using next-generation sequencing to profile 45,000+ bacteria and yeast from a single swab, serving women with recurrent infections, fertility concerns, and wellness interest via direct e-commerce, subscription, and a healthcare provider channel.
Ownership category
akta.pro rank

Juno Bio industry classification

Industry
Product category
Consumer Women's Health Diagnostics
NAICS
Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal) (HLAAAFAH)
akta.pro secondary industry
Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI)

Keywords

  • Vaginal microbiome testing
  • At-home diagnostic testing
  • Microbiome sequencing services
  • Women's health diagnostics
  • Microbiome bioinformatics

Where Juno Bio is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Juno Bio business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain

Revenue model

  1. Single Test Purchase: One-time purchase of vaginal microbiome test kit at $149.00. Includes complete bacterial and yeast microbiome profile, free US shipping, HSA/FSA eligibility, and 1:1 consultation with vaginal coach.
  2. Subscription Testing: Recurring subscription model delivering one test every 3 months at $99.00 (save $50 vs single purchase). Designed for ongoing monitoring of vaginal microbiome over time. Cancel anytime after minimum of two payments.
  3. Gift Cards: Juno Bio Gift Card ($149.00) and Vaginal Microbiome Test Gift Card ($174.00) available for purchase as gifts.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goSingle Test - One-time vaginal microbiome test
SubscriptionAnnualSubscription - Recurring 3-month testing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Juno Bio product offering

Product offering

Core offering

Juno Bio sells an at-home vaginal microbiome test kit that customers order online, self-collect via vaginal swab, and mail to a CLIA-certified lab for next-generation sequencing analysis. The company delivers a comprehensive bacterial and yeast microbiome profile (45,000+ microbes), Community State Type classification, microbial load analysis, and personalized recommendations through a private online dashboard, including a 1:1 consultation with a vaginal coach, with options for one-time purchase or a recurring 3-month subscription.

Product overview

Juno Bio offers a single primary product—the Juno Bio Vaginal Microbiome Test—alongside gift card variants. The core test is an at-home vaginal microbiome screening service using next-generation sequencing technology to provide comprehensive bacterial and yeast profiling. Results are delivered via a private dashboard with 1:1 consultation with a vaginal coach included. The company also offers gift cards for the test and a separate general gift card product.

Differentiator

Problem solved

Functional benefit

Products and services

  • Juno Bio Vaginal Microbiome Test An at-home vaginal microbiome test that uses next-generation sequencing to identify over 45,000 bacteria and yeast species from a single self-collected swab. Results are delivered within 5–10 days and include Community State Type classification, a full microbiome profile, and personalized wellness recommendations along with a 1:1 consultation with a vaginal coach; designed for adult women and people with vaginas seeking personal vaginal-health insights.
  • Juno Bio Gift Card A digital gift card (priced at $149.00) that grants the recipient access to Juno Bio's comprehensive at-home vaginal microbiome testing kit and detailed analysis report, delivered via email with an optional personalized message.
  • Juno Bio Vaginal Microbiome Test Gift Card A dedicated gift card (priced at $174.00) specifically for the Juno Bio Vaginal Microbiome Test, granting recipients personalized vaginal health insights and a comprehensive microbial composition analysis.

Quantifiable outcome

  • 10,000+ customers helped on their vaginal health journeys
  • +2 more outcomes

Companies that use Juno Bio

Customer profile

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Juno Bio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature4 records

Juno Bio partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • FlexcoreGTM or Marketing PartnerJuno Bio has partnered with Flex to enable customers to use their Health Savings Account (HSA) or Flexible Spending Account (FSA) to purchase vaginal microbiome tests. Flex provides an asynchronous telehealth visit as part of checkout, generating a Letter of Medical Necessity within 24 hours of purchase, enabling HSA/FSA payment and resulting in 30-40% net savings for customers.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Juno Bio competitors and assessment

Company assessment

Emerging players

  • Atlas Biomed: Atlas Biomed provides D2C gut microbiome and DNA testing using NGS with personalized recommendations. Broader indication set but similar NGS-D2C model.
  • Daye: UK-based vaginal health brand selling tampons, cramp care, and at-home screening. Same consumer segment with adjacent rather than overlapping microbiome testing focus.
  • Jona: Jona offers D2C gut microbiome sequencing with AI-driven personalized insights. Same NGS+AI+D2C axis but broader indication than Juno Bio's current niche.

Direct peers

  • Evvy: Evvy offers an at-home vaginal microbiome test using NGS with similar screening coverage and D2C positioning. Closest direct competitor to Juno Bio.
  • Tiny Health: Tiny Health provides NGS-based microbiome testing for women and infants with a D2C subscription model. Targets overlapping use cases including fertility and baby microbiome.
  • Viome: Viome sells D2C gut and oral microbiome tests using NGS + AI with subscription recommendations. Different indications but comparable technology and GTM motion.
  • Biohm: Biohm provides gut and vaginal microbiome testing for consumers and providers with personalized probiotic recommendations. Direct overlap in vaginal microbiome and provider channel.
  • Thryve: Thryve offers microbiome testing and personalized probiotics for consumers and brands. Direct overlap in microbiome sequencing services and recommendations.

Broad incumbents

  • Seed Health: Seed Health develops microbiome-based probiotics with consumer products and clinical research. Adjacent rather than direct — overlapping microbiome IP rather than head-to-head testing.
  • Thorne: Thorne is a large practitioner-grade supplements and at-home testing brand offering microbiome and women's health products as part of a broader portfolio rather than a vaginal specialist.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Juno Bio social profiles

Digital presence

Juno Bio compliance and trust

Trust signal

Compliance1 record

Juno Bio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Juno Bio leadership team

Management profile

Number of profiles

Profiles2 records

Juno Bio funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Juno Bio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Juno Bio

What does Juno Bio do?

Juno Bio sells an at-home vaginal microbiome test kit that customers order online, self-collect via vaginal swab, and mail to a CLIA-certified lab for next-generation sequencing analysis. The company delivers a comprehensive bacterial and yeast microbiome profile (45,000+ microbes), Community State Type classification, microbial load analysis, and personalized recommendations through a private online dashboard, including a 1:1 consultation with a vaginal coach, with options for one-time purchase or a recurring 3-month subscription.

Is Juno Bio a public or private company?

Juno Bio is a private company. It is classified as venture growth investor backed and is currently operating.

When was Juno Bio founded?

Juno Bio was founded in 2018. It employs 1 to 10 people.

Where is Juno Bio based?

Juno Bio is headquartered in London, United Kingdom, in the Europe region.

How does Juno Bio make money?

Three revenue lines are on record. Single Test Purchase is the primary driver. The others are subscription Testing and gift Cards.

Who are Juno Bio's main competitors?

Emerging players on record are Atlas Biomed, Daye and Jona. Direct peers are Evvy, Tiny Health, Viome, Biohm and Thryve. Broad incumbents are Seed Health and Thorne.

Does Juno Bio have an API?

No public API is recorded for Juno Bio.

What industry is Juno Bio in?

Juno Bio's product category is Consumer Women's Health Diagnostics. Its primary akta.pro industry code is HLAAAFAH, Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal), with a secondary code of HLAAAFAI, Microbiome Analytics, Sequencing & Bioinformatics Platforms. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
VestbeeTop European funding rounds closed in July 2026Vestbee compiled a list of European startups that closed funding rounds in July 2026, including microagi, Valarian Technologies, and Greenjets. The rounds ranged from $55M seed to €1.9M pre-seed, with investments in AI, robotics, and aerospace. The list covers startups across Germany, the UK, France, and other European countries.TrendHunter.comCertified Sequencing LaboratoriesJuno Bio, a women's health company focused on precision vaginal microbiome testing, has opened its first CLIA-certified sequencing laboratory in Oakland, California. The new facility enables the company to scale provider-led care and advance precision diagnostics, building on their original wellness test that sold over 20,000 units. The company has raised $3.8 million from investors including Ada Ventures, Artesian, Entrepreneur First, and Illumina Accelerator to support this growth.MedCity NewsJuno Bio Raises $3.8M to Support Vaginal HealthJuno Bio, a women's health company, announced it has secured $3.8 million in funding from Ada Ventures, Artesian, Entrepreneur First, and Illumina Accelerator to support the opening of its first CLIA-certified women's health sequencing lab in Oakland, California. The company offers an at-home vaginal microbiome test that screens for bacteria, fungi, and sexually transmitted infections, with data showing that 67.5% of customers had been incorrectly diagnosed before using the test. Juno Bio aims to scale its operations and expand access to more actionable care while addressing the gender health gap.FinSMEsJuno Bio Raises $3.8M in FundingJuno Bio, an Oakland-based developer of precision multi-omics and vaginal microbiome testing platforms, has raised $3.8 million in funding from investors including Ada Ventures, Artesian, Entrepreneur First, and Illumina Accelerator. The company plans to use the capital to expand its clinical testing infrastructure, accelerate pharmaceutical R&D partnerships, and scale diagnostic output from its newly opened sequencing facility. Juno Bio, originally founded in the United Kingdom, has surpassed 20,000 organic test sales addressing chronic misdiagnoses in menopausal health, fertility, and recurrent bacterial vaginosis.Pulse 2.0Juno Bio Raises $3.8 Million And Opens First CLIA-Certified Sequencing Lab Dedicated Entirely To Women’s HealthJuno Bio has opened its first CLIA-certified sequencing lab dedicated entirely to women's health in Oakland, California, and raised $3.8 million in funding from investors including Ada Ventures, Artesian, Entrepreneur First, and Illumina Accelerator. The company's new clinically actionable vaginal microbiome and STI test analyzes approximately 10,000 bacteria and fungi along with four common STIs, with company data showing that 67.5% of customers had been incorrectly diagnosed prior to using its test. The test is currently available in 46 states with additional expansion planned.PR NewswireJuno Bio Opens First CLIA-Certified Sequencing Lab Dedicated Entirely to Women's Health, Backed by Ada Ventures, Artesian, Illumina Accelerator, and Entrepreneur FirstJuno Bio has opened its first CLIA-certified sequencing lab dedicated entirely to women's health in Oakland, California, marking a major step in scaling provider-led care and advancing precision vaginal microbiome testing. To support this growth, the company raised $3.8 million in funding from Ada Ventures, Artesian, Illumina Accelerator, and Entrepreneur First. Juno Bio has sold more than 20,000 tests organically and launched a new clinically actionable test that analyzes approximately 10,000 bacteria and fungi along with four common STIs, with the test currently available in 46 states.FittJuno Bio Raises $3.8M to Expand Vaginal Microbiome TestingJuno Bio raised $3.8 million to open its first CLIA-certified sequencing lab and launch a vaginal microbiome and STI test. The company has sold over 20,000 at-home tests and is vertically integrating diagnostics to improve accuracy and data collection.Longevity.TechnologyStartup Juno Bio raises $3.8m for smarter women’s diagnosticsJuno Bio has secured $3.8 million in seed funding to expand its clinical diagnostics platform for women's health, with the round led by Ada Ventures and participation from Artesian, Entrepreneur First, and Illumina Accelerator. The funding will support launching the company's first CLIA-certified sequencing laboratory in Oakland, California, alongside a new clinical vaginal microbiome and STI test for healthcare providers. The company, which has already sold over 20,000 tests through its consumer offering, aims to transition from wellness testing into provider-led clinical care while building one of the largest datasets focused specifically on the vaginal microbiome.Tech Funding NewsAda Ventures and Illumina Accelerator back Juno Bio's $3.8M round to scale vaginal microbiome testing — TFNJuno Bio has raised $3.8 million in seed funding from Ada Ventures, Artesian, Entrepreneur First, and Illumina Accelerator to scale its precision vaginal microbiome testing platform. The Oakland-based startup simultaneously opened its first CLIA-certified sequencing lab dedicated entirely to women's health, enabling it to process tests internally rather than outsourcing. According to the company's clinical data, 67.5% of patients who later used its platform had previously been misdiagnosed, underdiagnosed, or overdiagnosed, and roughly half had co-infections that conventional testing missed.Tech.euJuno Bio secures $3.8M and opens first sequencing lab dedicated to women's healthJuno Bio raised $3.8 million and opened its first sequencing lab in Oakland, California, dedicated to women's health. The company's platform analyzes about 10,000 bacteria and fungi plus four STIs, and has sold over 20,000 tests organically. It aims to expand access to actionable vaginal microbiome testing.